Analysts Expect Corbus Pharmaceuticals (CRBP) Stock To Soar

 

Corbus Pharmaceuticals Holdings Inc (CRBP) stock has gained 20.82% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CRBP stock a score of 88 out of a possible 100.

That score is chiefly influenced by a long-term technical score of 93. CRBP’s score also includes a short-term technical score of 86. The fundamental score for CRBP is 84. In addition to the average rating from Wall Street analysts, CRBP stock has a mean target price of $25.00. This means analysts expect the stock to increase 239.21% over the next 12 months.

Click here to get the full Stock Score Report on CRBP.

What’s Happening with CRBP Stock Today

Corbus Pharmaceuticals Holdings Inc (CRBP) stock is lower by -5.54% while the S&P 500 has fallen -0.24% as of 12:35 PM on Monday, Apr 8. CRBP has fallen -$0.43 from the previous closing price of $7.80 on volume of 1,316,712 shares. Over the past year the S&P 500 has risen 10.44% while CRBP has gained 20.82%. CRBP lost -$0.98 per share the over the last 12 months.

Symbols: CRBP

You May Also Like